AMEX
| Health Care |
Biotechnology
AIM ImmunoTech Inc (AIM)
LAST (28 Mar)
Extended HOURS (00:00 PM ET)
MARKET CAP
VOLUME
| Open | 0.13 |
| Previous Close | 0.1279 |
| Day Range | 0.12 - 0.13 |
| 52-Week Range | 0.11 - 0.62 |
| All-Time High | 10,032.00 |
| Avg. Volume (50-day) | 1,103,444.8 |
| EPS (TTM) | -0.3129 |
| Next Earnings Date | - |
| Last Earnings Date | - |
| Forward Annual Dividend (Yield) | - |
| Trailing Annual Dividend (Yield) | - |
| Options | No |
| P/E Ratio | -0.2700 |
| PEG Ratio | - |
| Price to Book | 2.58 |
| Price to Cash Flow | - |
| Price to Free Cash Flow | - |
| Total Sales (TTM) | 0.19 M |
| Revenue per Share (TTM) | 0.00 |
| Shares Outstanding | 68.754 M |
| Share Float (%) | 60.63 M |
| % Held by Institutions | 6.76 |
| Dividends Per Share (TTM) | - |
| Ex-Dividend Date | - |
| +/- EMA(20) | 0.13 (-6.92%) |
| +/- SMA(50) | 0.15 (-19.33%) |
| +/- SMA(200) | 0.25 (-51.60%) |
| 5-Day Perf. | -14.79% |
| 1-Month Perf. | -10.37% |
| 3-Month Perf. | -41.91% |
| 6-Month Perf. | -56.79% |
| YTD Perf. | -38.89% |
| 1-Year Perf. | -74.31% |
| RSI(14) | 40.86 |
| ATR(14) | 0.01 |
| ADX(14) | 15.97 |
| Beta (5Y) | 0.71 |
FOR STOCKCHARTS MEMBERS ONLY
Unlock earnings and revenue history when you join StockCharts
As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!
AIM
AIM ImmunoTech Inc
Sector: Health Care
Industry: Biotechnology
Employees: 26
Description
AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.
AIM has triggered the following predefined scans:
| P&F Double Bottom Breakdown |
| P&F Descending Triple Bottom Breakdown |
FOR STOCKCHARTS MEMBERS ONLY
Unlock custom technical alerts when you join StockCharts
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
FOR STOCKCHARTS MEMBERS ONLY
Unlock ChartLists to save and organize your charts when you join StockCharts
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.
